Cargando…

Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients

PURPOSE: Delay performance of adjuvant chemotherapy (AC) after surgery has been presented to affect survival of breast cancer patients adversely, but the risk factors for delay in initiation remain controversial. Therefore, we conducted this systematic review of the literature and meta-analysis aimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiaofang, Ye, Fen, Zhao, Bingcheng, Tang, Hailin, Wang, Jin, Xiao, Xiangsheng, Xie, Xiaoming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354309/ https://www.ncbi.nlm.nih.gov/pubmed/28301555 http://dx.doi.org/10.1371/journal.pone.0173862

Ejemplares similares

Application of a novel prognostic invasive lesion index in ductal carcinoma in situ with minimal invasion of the breast
por: He, Xiaofang, et al.
Publicado: (2017)

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a
por: Huang, Xiaojia, et al.
Publicado: (2017)

High level of unmet needs and anxiety are associated with delayed initiation of adjuvant chemotherapy for colorectal cancer patients
por: Zhu, Li, et al.
Publicado: (2020)

The Aetiology of Delay to Commencement of Adjuvant Chemotherapy following Colorectal Resection
por: Simpson, G. S., et al.
Publicado: (2014)

Delayed initiation of adjuvant chemotherapy in older women with breast cancer
por: Smith‐Graziani, Demetria, et al.
Publicado: (2020)

The value of neutrophil-to-lymphocyte ratio for response and prognostic effect of neoadjuvant chemotherapy in solid tumors: A systematic review and meta-analysis
por: Li, Xuan, et al.
Publicado: (2018)

Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis
por: Zou, Yutian, et al.
Publicado: (2020)

Delay in the initiation of adjuvant chemotherapy in patients with breast cancer with mastectomy with or without immediate breast reconstruction
por: Huttunen, Tuomas, et al.
Publicado: (2022)

Diallyl Disulfide Suppresses SRC/Ras/ERK Signaling-Mediated Proliferation and Metastasis in Human Breast Cancer by Up-Regulating miR-34a
por: Xiao, Xiangsheng, et al.
Publicado: (2014)

Celecoxib as an adjuvant to chemotherapy for patients with metastatic colorectal cancer: A randomized controlled clinical study
por: Mostafa, Tarek M., et al.
Publicado: (2022)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
por: Chen, Yuanyuan, et al.
Publicado: (2022)

Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy
por: Harada, Kazuaki, et al.
Publicado: (2019)

Chemoradiation and the Role of Adjuvant Chemotherapy in Lymph Nodal–Metastatic Cervical Cancer
por: Ali, Nasir, et al.
Publicado: (2017)

Influence of delayed initiation of adjuvant chemotherapy on breast cancer survival is subtype-dependent
por: Yu, Ke-Da, et al.
Publicado: (2016)

Posterior decompression and occipitocervical fixation followed by intraoperative vertebroplasty for metastatic involvement of the axis
por: Wu, Xinjie, et al.
Publicado: (2018)

Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy
por: Liang, Ting, et al.
Publicado: (2022)

Factors Affecting Use and Delay (≥8 Weeks) of Adjuvant Chemotherapy after Colorectal Cancer Surgery and the Impact of Chemotherapy-Use and Delay on Oncologic Outcomes
por: Kim, Ik Yong, et al.
Publicado: (2015)

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer
por: Wen, Jiahuai, et al.
Publicado: (2016)

Adjuvant chemotherapy
por: Glimelius, B.
Publicado: (2013)

Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis
por: Zhao, Jun-hua, et al.
Publicado: (2016)

AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2018)

Corrigendum: AFAP1-AS1 Promotes Epithelial-Mesenchymal Transition and Tumorigenesis Through Wnt/β-Catenin Signaling Pathway in Triple-Negative Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2020)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Timing of Adjuvant Chemotherapy in Colorectal Cancer Patients
por: Baek, Moo-Jun
Publicado: (2013)

Adjuvant chemotherapy in elderly patients with pancreatic cancer
por: Nagrial, A M, et al.
Publicado: (2014)

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
por: Glimelius, Bengt, et al.
Publicado: (2020)

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer
por: Xiao, Xiangsheng, et al.
Publicado: (2016)

Impact of ERAS compliance on the delay between surgery and adjuvant chemotherapy in hepatobiliary and pancreatic malignancies
por: St-Amour, Pénélope, et al.
Publicado: (2020)

Comparison between adjuvant chemotherapy and adjuvant radiotherapy/chemoradiotherapy after radical surgery in patients with cervical cancer: a meta-analysis
por: Lee, Kwang-Beom, et al.
Publicado: (2018)

Clinical Impact of Delayed Initiation of Adjuvant Chemotherapy Among Patients With Stage II/III Gastric Cancer: Can We Do Better?
por: Chen, Qi-Yue, et al.
Publicado: (2020)

Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB Review
por: Rodriguez, Robin R., et al.
Publicado: (2021)

Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
por: Niu, Xiaoshuang, et al.
Publicado: (2021)

Efficacy of adjuvant treatment for fracture nonunion/delayed union: a network meta-analysis of randomized controlled trials
por: Yang, Jun, et al.
Publicado: (2022)

Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients
por: Li, Xuan, et al.
Publicado: (2018)

Association between delayed initiation of adjuvant CMF or anthracycline-based chemotherapy and survival in breast cancer: a systematic review and meta-analysis
por: Yu, Ke-Da, et al.
Publicado: (2013)

A network meta-analysis protocol of adjuvant chemotherapy for unresectable patients with advanced gastric cancer
por: Li, Long, et al.
Publicado: (2019)

Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis
por: Chao, Xue, et al.
Publicado: (2019)

Adjuvant chemotherapy for resected triple negative breast cancer patients: A network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2022)

Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis
por: Zhang, Yu-fei, et al.
Publicado: (2022)

Is adjuvant chemotherapy necessary in older patients with breast cancer?
por: Morita, Midori, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gh5r10rdnk9pj1s5354pc7ek6n